• To tell Amphista’s story to potential partners and investors and differentiate its technology in the protein degradation space
  • Announce Amphista’s USD 7.5m Series A financing, leading to raised awareness with potential partners, investors and employees, of the company’s work to advance targeted protein degradation assets in cancer


  • Acted as strategic communications advisor
  • Co-ordinated communications activities with third parties including investors
  • Drafting press releases and associated key messaging
  • Engaging with the media to tell Amphista’s story, and setting up interview


  • Secured significant coverage in top tier global trade media
  • Financing news directly led to recruitment of new Chief Scientific Officer